Indications and contraindications for Mosunetuzumab

The indications and contraindications of Mosunetuzumab (Mosunetuzumab) are important factors related to the safe and effective use of this drug. The following is an overview of the indications and contraindications for motuzumab:

Indications (Indications):

The primary indication for motuzumab is the treatment of adults with certain types of malignancies, specifically diffuse largeBcell lymphoma (DLBCL). Specifically, it applies to the following situations:

Relapsed or refractory diffuse large Bcell lymphoma (DLBCL): Motuzumab may be used as first-line treatment for DLBCL or as an alternative treatment option, especially in patients who are no longer sensitive to traditional treatments or have limited efficacy.

Contraindications (Contraindications):

Contraindications refer to situations where the use of a certain drug is unsafe or inappropriate and may pose a serious threat to the patient's health. For motuzumab, contraindications may include the following:

1.Known hypersensitivity to motuzumab or its components: If a patient has had an allergic reaction to motuzumab or its components, they should not use this drug because of the potential for severe allergic symptoms.

2.Pregnant and lactating women: The use of motuzumab during pregnancy may cause harm to the fetus, so its use by pregnant women is prohibited. In addition, lactating women also need to stop breastfeeding during treatment because motuzumab may be passed to the infant through breast milk.

It should be emphasized that indications and contraindications are determined based on the patient's specific circumstances and the physician's professional judgment. Before using motuzumab or any other drug, patients should consult a professional physician for a detailed evaluation of the drug's risks and benefits to ensure safe and effective treatment.